Proceedings of the Ninth International Conference of Drug Regulatory Authorities (ICDRA) - Berlin, Germany 25-29 April 1999
(1999; 102 pages) Voir le document au format PDF
Table des matières
Ouvrir ce répertoire et afficher son contenuOpening Ceremony
Ouvrir ce répertoire et afficher son contenuGood regulatory practice
Ouvrir ce répertoire et afficher son contenuGood certification practice
Ouvrir ce répertoire et afficher son contenuCounterfeit drugs: challenges and solutions
Ouvrir ce répertoire et afficher son contenuCurrent issues in regulation and quality
Ouvrir ce répertoire et afficher son contenuInternational Conference on Harmonization: implementation and implications
Ouvrir ce répertoire et afficher son contenuDrug utilization studies
Ouvrir ce répertoire et afficher son contenuInternational Conference on Harmonization and the common technical document
Ouvrir ce répertoire et afficher son contenuKeynote address
Fermer ce répertoireGlobal and national efforts to reduce tobacco use
Afficher le documentHow national authorities can promote non-smoking: experience from a European Union country
Afficher le documentInternational implications of the regulation of nicotine products
Afficher le documentPublic health responsibilities of nicotine regulation
Afficher le documentDiscussion
Afficher le documentRecommendations
Ouvrir ce répertoire et afficher son contenuElectronic communication in the regulatory process
Ouvrir ce répertoire et afficher son contenuTransparency in monitoring the safety of medicines
Ouvrir ce répertoire et afficher son contenuPharmaceutical products for use in special groups
Ouvrir ce répertoire et afficher son contenuNeed for Bioequivalence
Ouvrir ce répertoire et afficher son contenuAntimicrobial resistance: battling the bugs
Ouvrir ce répertoire et afficher son contenuSafety issues of plasma-derived medicinal products
Ouvrir ce répertoire et afficher son contenuHerbal medicines
Ouvrir ce répertoire et afficher son contenuRegulation and access to essential drugs
Afficher le documentParticipants
Afficher le documentBack cover
 

Global and national efforts to reduce tobacco use

Moderators: Dr Zhou Haijun, China, and Dr S. Nightingale, USA

The preceding keynote address by the Director-General of WHO drew attention to the heavy burden of disease due to tobacco smoking, and the need to control tobacco products. This opened discussions prior to the formal introduction of the topic by the two co-moderators.

In introducing the session, reference was made to action taken in this connection by the United States Food and Drug Administration (FDA) as a model for consideration at this forum. Also stressed was the need for political commitment to tobacco control at the highest level.

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013